Evercore ISI Group: Maintaining the Akero Therapeutics (AKRO.US) rating, adjusted from better than market to better than market rating, and adjusted the target price from $50.00 to $38.00.
Evercore ISI Group：维持Akero Therapeutics(AKRO.US)评级，由优于大市调整至优于大市评级, 目标价由50.00美元调整至38.00美元。
Evercore ISI Group: Maintaining the Akero Therapeutics (AKRO.US) rating, adjusted from better than market to better than market rating, and adjusted the target price from $50.00 to $38.00.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.